Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis

Immunomodulation in the acute phase of autoimmune encephalitis

(2022) N.L. Ciano-Petersen et al.   REVUE NEUROLOGIQUE

Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis

(2021) Margherita Nosadini et al.   JAMA Neurology

Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis

(2021) Nicolás Lundahl Ciano-Petersen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Predictive value of electroencephalography in anti-NMDA receptor encephalitis

(2018) Agnes van Sonderen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis

(2018) Ramani Balu et al.   NEUROLOGY

Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System

(2017) Josep Dalmau et al.   PHYSIOLOGICAL REVIEWS

CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review

(2016) Kavitha Kothur et al.   CYTOKINE

Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid

(2016) Zuzana Liba et al.   Journal of Neuroinflammation

A clinical approach to diagnosis of autoimmune encephalitis

(2016) Francesc Graus et al.   LANCET NEUROLOGY

Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis

(2016) Kavitha Kothur et al.   PLoS One

Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis

(2016) Takahiro Iizuka et al.   JAMA Neurology

Investigations on CXCL13 in Anti–N-Methyl-D-Aspartate Receptor Encephalitis

(2015) Frank Leypoldt et al.   JAMA Neurology

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

(2014) Jesús Planagumà et al.   BRAIN

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

(2013) Maarten J Titulaer et al.   LANCET NEUROLOGY

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

(2013) Nuria Gresa-Arribas et al.   LANCET NEUROLOGY

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis

(2012) C. G. Bien et al.   BRAIN

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis

(2012) Lenka Mikasova et al.   BRAIN

Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain

(2012) A. J. Gleichman et al.   JOURNAL OF NEUROSCIENCE

Persistent Intrathecal Antibody Synthesis 15 Years After Recovering From Anti– N-methyl-D-aspartate Receptor Encephalitis

(2012) Hans-Christian Hansen et al.   JAMA Neurology

Analysis of relapses in anti-NMDAR encephalitis

(2011) I. Gabilondo et al.   NEUROLOGY

N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

(2010) Sarosh R. Irani et al.   BRAIN

Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis

(2010) E. G. Hughes et al.   JOURNAL OF NEUROSCIENCE

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

(2010) Josep Dalmau et al.   LANCET NEUROLOGY

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

(2008) Josep Dalmau et al.   LANCET NEUROLOGY